Login

ENDOCYTE INC 4 SEC Filings

Filed On Filing
21 Dec 2018 Form 4: Middleton Fred A, Director

Gave 83,860 shares as a gift · Returned 4,159,106 shares to the issuer ($99.8M) · Disposed of 129,706 Stock Option (right to buy) (Disposition to Issuer) ($2.18M)

21 Dec 2018 Form 4: Machado Patrick, Director

Returned 7,050 shares to the issuer ($169K) · Disposed of 42,000 Stock Option (right to buy) (Disposition to Issuer) ($703K)

21 Dec 2018 Form 4: McAvoy David R., General Counsel

Returned 25,869 shares to the issuer ($621K) · Disposed of 37,500 Stock Option (right to buy) (Disposition to Issuer) ($789K)

21 Dec 2018 Form 4: Leamon Christopher P, Vice President of Research

Returned 224,256 shares to the issuer ($5.38M) · Disposed of 387,492 Stock Option (right to buy) (Disposition to Issuer) ($7M)

21 Dec 2018 Form 4: Armour Alison A., Chief Medical Officer

Gave 10,500 shares as a gift · Acquired 10,500 shares (Gift) · Returned 150,253 shares to the issuer ($3.61M) · 1 more

21 Dec 2018 Form 4: Parker Katherine, VP of Human Resources

Gave 8,229 shares as a gift · Returned 63,997 shares to the issuer ($1.54M) · Disposed of 166,500 Stock Option (right to buy) (Disposition to Issuer) ($3.22M)

21 Dec 2018 Form 4: Russell Lesley, Director

Returned 11,100 shares to the issuer ($266K) · Disposed of 122,000 Stock Option (right to buy) (Disposition to Issuer) ($2M)

21 Dec 2018 Form 4: Chelius Erik C., Vice President CMC

Returned 49,895 shares to the issuer ($1.2M) · Disposed of 124,893 Stock Option (right to buy) (Disposition to Issuer) ($2.4M)

21 Dec 2018 Form 4: Aplin John C, Director

Returned 32,163 shares to the issuer ($772K) · Disposed of 129,706 Stock Option (right to buy) (Disposition to Issuer) ($2.18M)

21 Dec 2018 Form 4: Taylor Beth, VP Finance & Chief Acctg Off

Returned 99,509 shares to the issuer ($2.39M) · Disposed of 100,261 Stock Option (right to buy) (Disposition to Issuer) ($1.86M)

21 Dec 2018 Form 4: Goddard Colin, Director

Returned 11,100 shares to the issuer ($266K) · Disposed of 108,000 Stock Option (right to buy) (Disposition to Issuer) ($1.83M)

21 Dec 2018 Form 4: Svoronos Dawn, Director

Returned 7,050 shares to the issuer ($169K) · Disposed of 42,000 Stock Option (right to buy) (Disposition to Issuer) ($554K)

21 Dec 2018 Form 4: Kozin Marc D, Director

Returned 11,100 shares to the issuer ($266K) · Disposed of 114,000 Stock Option (right to buy) (Disposition to Issuer) ($1.93M)

21 Dec 2018 Form 4: Sherman Michael A., Director

Returned 399,284 shares to the issuer ($9.58M) · Disposed of 835,512 Stock Option (right to buy) (Disposition to Issuer) ($16.6M)

21 Dec 2018 Form 4: Low Philip S, Director

Returned 542,417 shares to the issuer ($13M) · Disposed of 377,990 Stock Option (right to buy) (Disposition to Issuer) ($6.91M)

21 Dec 2018 Form 4: Andriole Michael T., Chief Financial Officer

Returned 152,582 shares to the issuer ($3.66M) · Disposed of 125,000 Stock Option (right to buy) (Disposition to Issuer) ($2.68M)

19 Dec 2018 Form 4: Taylor Beth, VP Finance & Chief Acctg Offcr

Received 48,854 shares by exercise or conversion ($211K) · Gave 3,750 shares as a gift · Acquired 1,250 shares (Gift) · 1 more

19 Dec 2018 Form 4: Leamon Christopher P, Vice President of Research

Received 101,774 shares by exercise or conversion ($523K)

19 Dec 2018 Form 4: Andriole Michael T., Chief Financial Officer

Received 25,000 shares by exercise or conversion ($55.5K) · Gave 4,500 shares as a gift

19 Dec 2018 Form 4: Armour Alison A., Chief Medical Officer

Received 49,213 shares by exercise or conversion ($226K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support